sermo

  1. T

    Sermo Report Indicates That Ticagrelor Is Likely To Affect The Standard Of Care For A

    Sermo, the world's largest online community for physicians, announced a free Sermo Report titled, "FDA Committee Recommends Approval for Ticagrelor." The report covers physician opinions about the introduction of an investigational oral antiplatelet treatment for acute coronary syndrome (ACS)...
Back
Top